Systemic lupus erythematosus is associated with substantial morbidity and involves major organs including the kidneys and the CNS. Based on randomized, controlled trials and long-term ...

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

UCB and Biogen have announced positive Phase III clinical trial results for PHOENYCS GO study, evaluating dapirolizumab pegol, a new treatment for moderate-to-severe systemic lupus erythematosus (SLE) ...

Neuropsychiatric systemic lupus erythematosus ... understanding and managing NPSLE, further research and clinical studies for ...

(KTAL/KMSS) – Willis Knighton Health is researching a treatment for systemic lupus erythematosus (SLE), and you can help.

Systemic lupus erythematosus ... treatments rely on clinical experience. This Review covers recent clinical advances in this area and emphasizes the need for further research.

The trial met its primary composite endpoint demonstrating significant clinical improvement ... in patients with moderate to severe systemic lupus erythematosus (SLE). Dapirolizumab pegol is ...

Phase 1 clinical trial is designed to assess the safety, pharmacokinetics and initial clinical activity of CLN-978 for patients with systemic lupus erythematosus The trial will be conducted in ...

Roivant and Priovant have reported that their Phase II clinical trial of oral brepocitinib to treat adults with moderate to severe systemic lupus erythematosus (SLE) has failed to meet its primary ...

Investing in Cabaletta Bio for potential high returns on innovative CAR-T therapies despite volatility and risk. Click here ...

In spite of considerable achievements, treatment of established lupus is a difficult task. Complete remission of mild disease with mucocutaneus or joint disease remains a challenge with a ...